This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Dec;52(6):512-4.

CAGS and ACS evidence based reviews in surgery. 31. The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis

Prosanto Chaudhury, Jeffrey Barkun, John Marshall, Lena Napolitano; Evidence Based Reviews in Surgery Group

Collaborators

Collaborators

Evidence Based Reviews in Surgery Group:
N N Baxter, K J Brasel, C J Brown, P Chaudhury, T H Cogbill, C S Cutter, E Dixon, G W N Fitzgerald, H J A Henteleff, A W Kirkpatrick, S Latosinsky, A MacLean, T M Mastracci, R S McLeod, A Morris, L A Neumayer, S Smith, L R Temple, M E McKenzie

PMID: 20011189
PMCID: PMC2792411

Comment

CAGS and ACS evidence based reviews in surgery. 31. The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis

Prosanto Chaudhury et al. Can J Surg. 2009 Dec.

. 2009 Dec;52(6):512-4.

Authors

Prosanto Chaudhury, Jeffrey Barkun, John Marshall, Lena Napolitano; Evidence Based Reviews in Surgery Group

Collaborators

Evidence Based Reviews in Surgery Group:
N N Baxter, K J Brasel, C J Brown, P Chaudhury, T H Cogbill, C S Cutter, E Dixon, G W N Fitzgerald, H J A Henteleff, A W Kirkpatrick, S Latosinsky, A MacLean, T M Mastracci, R S McLeod, A Morris, L A Neumayer, S Smith, L R Temple, M E McKenzie

PMID: 20011189
PMCID: PMC2792411

No abstract available

PubMed Disclaimer

Comment on

Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet). Brunkhorst FM, et al. N Engl J Med. 2008 Jan 10;358(2):125-39. doi: 10.1056/NEJMoa070716. N Engl J Med. 2008. PMID: 18184958 Clinical Trial.

Similar articles

Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet). Brunkhorst FM, et al. N Engl J Med. 2008 Jan 10;358(2):125-39. doi: 10.1056/NEJMoa070716. N Engl J Med. 2008. PMID: 18184958 Clinical Trial.
Effect of intensive insulin therapy and pentastarch resuscitation on acute kidney injury in severe sepsis.
Thomas G, Balk EM, Jaber BL. Thomas G, et al. Am J Kidney Dis. 2008 Jul;52(1):13-7. doi: 10.1053/j.ajkd.2008.04.008. Epub 2008 Jun 2. Am J Kidney Dis. 2008. PMID: 18514991 No abstract available.
Effects of hydroxyethyl starch resuscitation on extravascular lung water and pulmonary permeability in sepsis-related acute respiratory distress syndrome.
Huang CC, Kao KC, Hsu KH, Ko HW, Li LF, Hsieh MJ, Tsai YH. Huang CC, et al. Crit Care Med. 2009 Jun;37(6):1948-55. doi: 10.1097/CCM.0b013e3181a00268. Crit Care Med. 2009. PMID: 19384203
What is the Preferred Resuscitation Fluid for Patients with Severe Sepsis and Septic Shock?
Winters ME, Sherwin R, Vilke GM, Wardi G. Winters ME, et al. J Emerg Med. 2017 Dec;53(6):928-939. doi: 10.1016/j.jemermed.2017.08.093. Epub 2017 Oct 25. J Emerg Med. 2017. PMID: 29079487 Review.
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Dellinger RP, et al. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. Crit Care Med. 2013. PMID: 23353941

See all similar articles

Cited by

Hyperglycemia increases the complicated infection and mortality rates during induction therapy in adult acute leukemia patients.
Matias Cdo N, Lima V, Teixeira HM, Souto FR, Magalhães V. Matias Cdo N, et al. Rev Bras Hematol Hemoter. 2013;35(1):39-43. doi: 10.5581/1516-8484.20130013. Rev Bras Hematol Hemoter. 2013. PMID: 23580883 Free PMC article.

References

1. Evidence-Based Medicine Working Group. Evidence-based medicine. JAMA. 1992;268:2420–5. - PubMed
1. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ. 1998;316:961–4. - PMC - PubMed
1. Finfer S, Bollomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56. - PubMed
1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67. - PubMed
1. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources